Compare RNA & VERI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RNA | VERI |
|---|---|---|
| Founded | 2012 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 227.6M | 269.0M |
| IPO Year | 2025 | 2017 |
| Metric | RNA | VERI |
|---|---|---|
| Price | $13.08 | $2.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 5 |
| Target Price | ★ $69.26 | $10.00 |
| AVG Volume (30 Days) | ★ 2.1M | 1.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.36 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $92,637,000.00 |
| Revenue This Year | $88.12 | $20.56 |
| Revenue Next Year | $18.11 | $19.11 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.06 | $1.29 |
| 52 Week High | $73.06 | $9.42 |
| Indicator | RNA | VERI |
|---|---|---|
| Relative Strength Index (RSI) | 5.61 | 39.03 |
| Support Level | $13.06 | $2.61 |
| Resistance Level | $72.52 | $3.19 |
| Average True Range (ATR) | 1.05 | 0.19 |
| MACD | -0.24 | 0.03 |
| Stochastic Oscillator | 3.62 | 23.17 |
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.
Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has a presence in the United States, the United Kingdom, France, Australia, Israel, and India.